$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
pacritinib获加速批准用于治疗伴严重血小板减少症的骨髓纤维化
2025-10-19 11:44:20
Check Details
在国内能买到菲卓替尼Inrebic吗?多少钱一盒
2025-10-19 11:44:20
Check Details
菲卓替尼Inrebic一天需要用几次?长期治疗会耐药吗
2025-10-19 11:44:20
Check Details
鲁可替尼副作用该怎么处理?
2025-10-19 11:44:20
Check Details
鲁可替尼副作用是什么?
2025-10-19 11:44:20
Check Details
鲁可替尼不良反应是什么?
2025-10-19 11:44:20
Check Details
芦可替尼的常见不良反应
2025-10-19 11:44:20
Check Details
骨髓纤维化药物鲁可替尼常见副作用有什么?
2025-10-19 11:44:20
Check Details
芦可替尼的副作用
2025-10-19 11:44:20
Check Details
鲁索替尼的常见副作用
2025-10-19 11:44:20
Check Details
鲁可替尼副作用大吗?
2025-10-19 11:44:20
Check Details
鲁索替尼常见不良反应是什么?
2025-10-19 11:44:20
Check Details
1
2
...
128
129
130
131
132
133
134
...
940
941
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
How to Take Selinexor: Dosing, Food, and Safety
2
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
3
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
4
Key points for drug monitoring of Molotinib in bone marrow fibrosis
5
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
6
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
7
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
8
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
9
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
10
Revumenib: Key Considerations Before and During Treatment
11
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
12
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use